Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
| Status: | Completed |
|---|---|
| Conditions: | Podiatry |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/22/2018 |
| Start Date: | March 21, 2016 |
| End Date: | June 21, 2018 |
A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical Study to Assess the Efficacy, Safety and Tolerability Patients With Mild to Moderate Onychomycosis
A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical
Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical
product in Patients with Mild to Moderate Onychomycosis
Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical
product in Patients with Mild to Moderate Onychomycosis
Evaluate safety and tolerability of the two regimens of NVXT (Treatment Groups A and B) in
patients with mild to moderate distal subungual onychomycosis of the target toenail.
patients with mild to moderate distal subungual onychomycosis of the target toenail.
Inclusion Criteria:
- Clinical diagnosis of onychomycosis of the target toenail (defined as one of the
infected great toenails).
Exclusion Criteria:
- Females who are pregnant, lactating or likely to become pregnant during the study.
We found this trial at
1
site
225 West Station Square Drive
Pittsburgh, Pennsylvania 15219
Pittsburgh, Pennsylvania 15219
Phone: 412-363-3300
Click here to add this to my saved trials
